Webinar | A robust and scalable suspension platform for AAV manufacturing

News & MediaSeptember 18, 2023

A robust and scalable suspension platform for AAV manufacturing by Dr Samir Acharya

As you prepare to manufacture your Adeno-Associated Virus (AAV) vectors, you may face some hurdles such as scalability, production yields, and a clean feed-stream to facilitate effective purification strategies.

At Andelyn, we have developed a high yielding, scalable suspension platform that helps you overcome these challenges.

In this webinar, you’ll learn how our platform helps you:

  • Scale up your production: Discover how our DOE-based strategy helps ensure a scalable process to help you ramp up your production efforts.
  • Achieve efficiency in transfection: Learn more about how our FectoVIR®-AAV transfection reagent combined with a triple transient transfection approach enables us to optimize factors such as cell density, plasmid DNA amount, and more.
  • Overcome purification problems: Find out how our cutting-edge ultracentrifugation and all-column chromatography-based purification methods help you optimize AAV purification.

You’ll also hear real-world case studies demonstrating our scalability while learning more about our suspension cell line designed to help you achieve higher AAV yields.

Fill out the form on the right to view the webinar.